Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis). - Gargiulo, Luigi; Ibba, Luciano; Alfano, Angela; Malagoli, Piergiorgio; Amoruso, Fabrizio; Balato, Anna; Barei, Francesca; Burroni, Anna G.; Caccavale, Stefano; Calzavara-Pinton, Piergiacomo; Esposito, Maria; Fargnoli, Maria C.; et al. (Journal of Dermatological Treatment, 2024)